AFMD - Affimed N V Stock Trading

Image source: The Motley Fool. Affimed N.V.   (NASDAQ: AFMD) Q2 2020 Earnings Call Aug 11, 2020 , 8:30 a.m. ET Operator Continue reading

Continued progress in the AFM13 pTCL REDIRECT monotherapy study AFM24 is recruiting patients in cohort 2 of a Phase 1/2a clinical trial Genentech’s RO7297089 is actively recruiting patients into a first-in-human Phase I trial resulting in the achievement of a milestone payment un...

Heidelberg, Germany, August 5, 2020 –  Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the appointments of Dr. Annalisa Jenkins and Mr. Harry Welten to its Superv...